news bytes
Panacea Biotec
launches novel ‘EasySix’
vaccine for newborns
Delhi based Panacea
Biotec recently
announced the launch
of EasySix, a liquid
hexavalent combination
vaccine indicated for
immunisation of newborn
babies against common
preventable diseases.
This is world’s first
fully liquid whole cell
pertussis based vaccine
and would work against
diseases as diphtheria,
tetanus, whooping cough,
meningitis, hepatitis B
and polio, Panacea Biotec
said in a statement.
Commenting on the
development Panacea
Biotec Joint Managing
Director Rajesh Jain
said: “After 10 years of
consistent R&D effort,
Panacea Biotech takes
immense pleasure and is
proud to introduce world’s
first fully liquid WP based
hexavalent vaccine.”
64
BioVoiceNews | May 2017
As per the company, the
EasySix has been found
to be “immunogenic, safe
and well tolerated” in
phase I and III clinical
trials conducted in
various hospitals across
India. Pancea Biotec
has been developing
superior innovative
vaccines against infective
diseases for more
than three decades.
CSIR’s TKDL prevents
granting of wrong
patents in biodiversity
219 cases
As per the information
received from Council
for Scientific & Industrial
Research (CSIR),
till date Traditional
Knowledge Digital
Library (TKDL) has been
successful in preventing
the grant of wrong
patents in 219 cases.
The Ministry of AYUSH
had established TKDL in
collaboration with CSIR.
The TKDL consist of more
than 3.30 lakh medicinal
formulations of Ayurveda,
Unani, Siddha and Yoga
which are available in
the public domain, in five
international languages
namely English, Japanese,
French, German and
Spanish. To facilitate the
protection of country’s
traditional knowledge,
access of TKDL has been
provided to International
Patent offices (IPOs)
under International
Agreement. In addition,
pre-grant opposition on
patent applications along
with prior art evidence
from TKDL are submitted
on a regular basis.
As per the information
provided by the CSIR,
the implementing agency
of the TKDL project, the
expenditure incurred on
the project is about Rs
16.18 Crores during the
financial year 2012-2017.
Strand Life Sciences
launches ground-
breaking method for
monitoring cancer
According to data from
the Indian Council of
Medical Research (ICMR),
India is projected to have
17.3 lakhs new cases